|
Glycidol | CAS 556-52-5 | ||
C3H6O2 | RTECS UB4375000 | ||
Synonyms & Trade Names 2,3-Epoxy-1-propanol; Epoxypropyl alcohol; Glycide; Hydroxymethyl ethylene oxide; 2-Hydroxymethyl oxiran; 3-Hydroxypropylene oxide |
DOT ID & Guide |
Exposure Limits |
NIOSH REL: TWA 25 ppm (75 mg/m3) | ||
OSHA PEL�: TWA 50 ppm (150 mg/m3) | |||
IDLH 150 ppm | Conversion 1 ppm = 3.03 mg/m3 |
Physical Description Colorless liquid. |
|||
MW: 74.1 |
BP: 320°F (Decomposes) |
FRZ: -49°F |
Sol: Miscible |
VP(77°F): 0.9 mmHg |
IP: ? |
|
Sp.Gr: 1.12 |
Fl.P: 162°F |
UEL: ? |
LEL: ? |
|
Class IIIA Combustible Liquid: Fl.P. at or above 140�F and below 200�F. | |||
Incompatibilities & Reactivities Strong oxidizers, nitrates |
Measurement Methods NIOSH 1608; OSHA 7 |
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
Respirator Recommendations
NIOSH Up to 150 ppm: (APF = 10) Any supplied-air respirator*/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, skin, nose, throat; narcosis | |
Target Organs
Eyes, skin, respiratory system, central nervous system |
See also: INTRODUCTION |